International Journal of Cancer Management

Published by: Kowsar

The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia

Abolghasem Allahyari 1 , Seyed-Mehdi Hashemi 2 , Fahimeh Nazemian 3 , Mohammad Karimi 1 , Mohammad-Reza Kazemi 1 and Masoud Sadeghi 4 , *
Authors Information
1 Department of Hematology and Medical Oncology, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Hematology and Medical Oncology, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Cancer Research Center, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: August 2016, 9 (4); e5045
  • Published Online: August 10, 2016
  • Article Type: Research Article
  • Received: December 14, 2015
  • Revised: February 6, 2016
  • Accepted: August 6, 2016
  • DOI: 10.17795/ijcp-5045

To Cite: Allahyari A, Hashemi S, Nazemian F, Karimi M, Kazemi M, et al. The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia, Int J Cancer Manag. 2016 ; 9(4):e5045. doi: 10.17795/ijcp-5045.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Levitt L, Lin R. Biology and treatment of adult acute lymphoblastic leukemia. West J Med. 1996; 164(2): 143-55[PubMed]
  • 2. Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013; 50(3): 185-96[DOI][PubMed]
  • 3. Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, et al. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014; 9(1)[DOI][PubMed]
  • 4. Ahmed MB, Shehata HH, Moussa M, Ibrahim TM. Prognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemia. Clin Biochem. 2012; 45(1-2): 112-6[DOI][PubMed]
  • 5. Gokbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Semin Hematol. 2009; 46(1): 64-75[DOI][PubMed]
  • 6. Ibrahim A, Ali A, Mohammed MM. Outcome of Adolescents with Acute Lymphoblastic Leukemia Treated by Pediatrics versus Adults Protocols. Adv Hematol. 2014; 2014: 697675[DOI][PubMed]
  • 7. Rowe JM. Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol. 2010; 150(4): 389-405[DOI][PubMed]
  • 8. Rowe JM. Getting to the root of (it) ALL. Blood. 2010; 115(18): 3649-50[DOI][PubMed]
  • 9. Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P, et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica. 2013; 98(11): 1702-10[DOI][PubMed]
  • 10. Larson RA. Acute lymphoblastic leukemia: older patients and newer drugs. Hematology Am Soc Hematol Educ Program. 2005; : 131-6[DOI][PubMed]
  • 11. Wiernik PH, Dutcher JP, Paietta E, Gucalp R, Markus S, Weinberg V, et al. Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Leukemia. 1993; 7(8): 1236-41[PubMed]
  • 12. Park SR, Kim JH, Kim DY, Lee S, Lee SY, Choi IS, et al. Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors. Korean J Intern Med. 2003; 18(1): 21-8[PubMed]
  • 13. Mashhadi MA, Koushyar MM, Mohammadi M. Outcome of adult acute lymphoblastic leukemia in South East of iran (zahedan). Iran J Cancer Prev. 2012; 5(3): 130-7[PubMed]
  • 14. Gokbuget N. How I treat older patients with ALL. Blood. 2013; 122(8): 1366-75[DOI][PubMed]
  • 15. Thomas X, Danaila C, Le QH, Sebban C, Troncy J, Charrin C, et al. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period. Leukemia. 2001; 15(12): 1811-22[PubMed]
  • 16. Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N, et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004; 22(20): 4075-86[DOI][PubMed]
  • 17. Marcus RE, Catovsky D, Johnson SA, Gregory WM, Talavera JG, Goldman JM, et al. Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period. Br J Cancer. 1986; 53(2): 175-80[PubMed]
  • 18. Ayremlou P, Razavi SM, Solaymani-Dodaran M, Vakili M, Asadi-Lari M. Demographic and prognostic factors of 455 patients with acute leukemia admitted to two referral hospitals in tehran-iran during ten years (2001-2011). Iran J Cancer Prev. 2012; 5(3): 157-63[PubMed]
  • 19. Mandhaniya S, Swaroop C, Thulkar S, Vishnubhatla S, Kabra SK, Xess I, et al. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study. J Pediatr Hematol Oncol. 2011; 33(8)-41[DOI][PubMed]
  • 20. Heil G, Hoelzer D, Sanz MA, Lechner K, Liu Yin JA, Papa G, et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood. 1997; 90(12): 4710-8[PubMed]
  • 21. Eriksson U, Seifert B, Schaffner A. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ. 2001; 322(7286): 579-82[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments